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Abstract
Throughout life, oligodendrocyte progenitor cells (OPCs) proliferate and differentiate
into myelinating oligodendrocytes. OPCs express cell surface receptors and channels
that allow them to detect and respond to neuronal activity, including voltage-gated
calcium channel (VGCC)s. The major L-type VGCC expressed by developmental
OPCs, CaV1.2, regulates their differentiation. However, it is unclear whether CaV1.2
similarly influences OPC behavior in the healthy adult central nervous system (CNS).
To examine the role of CaV1.2 in adulthood, we conditionally deleted this channel
from OPCs by administering tamoxifen to P60 Cacna1cfl/fl (control) and Pdgfrα-
CreER:: Cacna1cfl/fl (CaV1.2-deleted) mice. Whole cell patch clamp analysis revealed
that CaV1.2 deletion reduced L-type voltage-gated calcium entry into adult OPCs by
~60%, confirming that it remains the major L-type VGCC expressed by OPCs in
adulthood. The conditional deletion of CaV1.2 from adult OPCs significantly
increased their proliferation but did not affect the number of new oligodendrocytes
produced or influence the length or number of internodes they elaborated. Unex-
pectedly, CaV1.2 deletion resulted in the dramatic loss of OPCs from the corpus
callosum, such that 7 days after tamoxifen administration CaV1.2-deleted mice had
an OPC density ~42% that of control mice. OPC density recovered within 2 weeks of
CaV1.2 deletion, as the lost OPCs were replaced by surviving CaV1.2-deleted OPCs.
As OPC density was not affected in the motor cortex or spinal cord, we conclude
that calcium entry through CaV1.2 is a critical survival signal for a subpopulation of
callosal OPCs but not for all OPCs in the mature CNS.
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1 | INTRODUCTION
Oligodendrocyte progenitor cells (OPCs) are immature, proliferative
cells that differentiate into mature, myelinating oligodendrocytes in
the central nervous system (CNS). OPCs generate large numbers of
oligodendrocytes shortly after birth and continue to divide and gener-
ate new oligodendrocytes throughout life (reviewed by Richardson,
Young, Tripathi, and McKenzie (2011)). They express receptors and
ion channels that allow them to detect and respond to neuronal activ-
ity (reviewed by Larson, Zhang, and Bergles (2015)), and it is well
established that neuronal activity can modulate OPC behavior,
influencing migration, proliferation and differentiation (reviewed by
Wang and Young (2014), Fields (2015), and Purger, Gibson, and
Monje (2015)). One category of ion channel that is expressed by
OPCs is the voltage-gated calcium channels (VGCCs; Borges,
Wolswijk, Ohlemeyer, & Kettenmann, 1995; Haberlandt et al., 2011).
As VGCCs are important for the ability of other cell types to translate
an activity-induced change in membrane potential into a calcium-
dependent response, such as the release of neurotransmitters or
altered gene expression (reviewed by Striessnig et al. (2006)), calcium
entry through VGCCs on OPCs may similarly transduce activity-
dependent changes in OPC behavior (reviewed by Pitman and
Young (2016)).
OPCs predominantly express two classes of VGCCs, the L-type
and T-type channels (Fulton et al., 2010; Haberlandt et al., 2011). The
L-type channel CaV1.2, encoded by the gene Cacna1c, is the major
channel responsible for depolarization-induced calcium entry into
developmental OPCs, as measured by calcium imaging in vitro (Cheli
et al., 2016; Cheli, Santiago González, Spreuer, & Paez, 2015) and
ex vivo (Cheli et al., 2016). The conditional deletion of CaV1.2 from
OPCs in the early postnatal mouse CNS leads to hypomyelination of
the corpus callosum and cortex (Cheli et al., 2016). While OPC prolif-
eration was reduced in the corpus callosum, and brain slice culture
experiments suggested that CaV1.2 was also required for OPC migra-
tion, the hypomyelination was largely attributed to the impaired ability
of OPCs to generate myelinating oligodendrocytes (Cheli et al., 2016).
Consistent with this finding, the deletion of CaV1.2 from adult
OPCs was reported to reduce their capacity to remyelinate the corpus
callosum following cuprizone-induced demyelination (Santiago
González et al., 2017), suggesting that CaV1.2 can, at least following
an injury, regulate adult OPC function. However, it is also possible
that CaV1.2 may differentially regulate developmental versus adult
OPCs or OPCs in the healthy versus injured CNS. In mice, OPCs are
known to undergo age-related changes, including the slowing of prolif-
eration with increasing postnatal age (Clarke et al., 2012; Young et al.,
2013) and the reduction of voltage-gated sodium channel expression
between development (P6-16) and adulthood (>P80) (Spitzer et al.,
2019). Furthermore, a transcriptomics analysis of adult OPCs has indi-
cated that they are more similar to oligodendrocytes than they are to
neonatal OPCs (Moyon et al., 2015). Herein, we show that adult OPCs
express L-type VGCCs at similar levels to their developmental counter-
parts, and while the deletion of CaV1.2 from adult OPCs increases their
proliferation, it does not affect oligodendrogenesis or myelination.
Instead, the deletion of CaV1.2 triggers the apoptotic cell death and
loss of approximately half of all adult OPCs from the corpus callosum
without affecting the survival of OPCs located in the motor cortex or
spinal cord. These data indicate that CaV1.2 is an essential survival sig-
nal for a subset of adult OPCs in the corpus callosum.
2 | MATERIALS AND METHODS
2.1 | Animals and housing
All animal experiments were approved by the University of Tasmania
Institutional Biosafety Committee and Animal Ethics Committee
(A0013741 and A0016151) and were carried out in accordance with
the Australian code of practice for the care and use of animals for sci-
entific purposes. All mice were maintained on a C57bl/6 background
and housed in optimice microisolator cages (Animal Care Systems,
Centennial, CO) on a 12-hr light/dark cycle at 20C. Male and female
mice were weaned after P30, to allow normal myelin development,
and housed with gender-matched littermates. Food and water were
available ad libitum. Heterozygous Pdgfrα–H2BGFP (Pdgfrα-hGFP;
Hamilton, Klinghoffer, Corrin, & Soriano, 2003), heterozygous Pdgfrα-
CreER (Kang, Fukaya, Yang, Rothstein, & Bergles, 2010), heterozygous
Tau-lox-STOP-lox-mGFP-IRES-NLS-LacZ-pA (Tau-mGFP; Hippenmeyer
et al., 2005) and homozygous Cacna1c floxed (Cacna1cfl/fl;
Seisenberger et al., 2000) transgenic mice were purchased from Jack-
son Laboratories. Heterozygous Pdgfrα-CreERT2 (Rivers et al., 2008)
transgenic mice were a kind gift from Prof William D Richardson
(University College London). In text, CaV1.2-deleted mice refer to
mice that carry the Pdgfrα-CreER or Pdgfrα-CreERT2 transgene and two
floxed copies of the Cacna1c gene (Cacna1cfl/fl). Control mice (CTRL)
refer to mice that either carry the Pdgfrα-CreER or Pdgfrα-CreERT2
transgene, but have a normal Cacna1c gene, or lack the Pdgfrα-CreER
or Pdgfrα-CreERT2 transgene, but carry the floxed Cacna1c gene
(Cacna1cfl/fl). These mouse lines were inter-crossed at the University
of Tasmania to generate the experimental mice used for this study.
Please note that two distinct Pdgfrα-CreER transgenic mouse lines
were used in this study, each maintained as a heterozygous stock line:
the Pdgfrα-CreER transgenic mouse line generated by Kang et al.
(2010) was used for the majority of experiments, while the Pdgfrα-
CreERT2 transgenic mouse line generated by Rivers et al. (2008) was
used to perform the Tau-mGFP lineage tracing experiments only
(Figure 3). When either line is crossed with the Rosa26-YFP cre-
sensitive reporter mouse (Srinivas et al., 2001) and Tamoxifen admin-
istered to adult offspring, they specifically label and enable the lineage
tracing of OPCs within the CNS (O'Rourke et al., 2016; Rivers et al.,
2008). As Cacna1c is located on the same chromosome as Rosa26, we
instead crossed each Pdgfrα-CreER line with the Tau-mGFP reporter
mouse line (Hippenmeyer et al., 2005) and administered Tamoxifen to
the adult offspring. The Pdgfrα-CreERT2 (Rivers et al., 2008) cross
resulted in the mGFP-labeling of a subset of adult OPCs and the new
oligodendrocytes they produce (as per Young et al., 2013 and
Figure 3). By contrast, the Pdgfrα-CreER (Kang et al., 2010) cross
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resulted in extensive and seemingly nonspecific mGFP labeling
throughout the CNS (Figure S1) and prevented our use of this mouse
line for lineage tracing.
2.2 | Genotyping of transgenic mice
Ear biopsies were digested in 100 mM Tris–HCl, 5 mM EDTA,
200 mM NaCl, and 0.2% SDS containing 0.48 mg/mL proteinase K
(ThermoFisher Scientific). The cellular and histone proteins were
precipitated by exposure to 6 M ammonium acetate (Sigma) and incu-
bation on ice. After centrifugation, the DNA was precipitated from
the supernatant by exposure to isopropyl alcohol (Sigma). The DNA
pellet was washed in 70% ethanol (Sigma), resuspended in sterile
MilliQ water and used as template DNA to genotype the mice by
polymerase chain reaction (PCR). The PCR was performed as a 25 μL
reaction containing: 50–100 ng DNA, 0.5 μL of each primer
(100 nmol/mL; Integrated DNA Technologies) and 12.5 μL GoTaq
green master mix (Promega) in MilliQ water. The following primer
combinations were used: Cre 50 CAG GTC TCA GGA GCT ATG TCC
AAT TTA CTG ACC GTA and Cre 30 GGT GTT ATA AGC AAT CCC
CAG AA; GFP 50 CCC TGA AGT TCA TCT GCA CCA C, and GFP 30
TTC TCG TTG GGG TCT TTG CTC; or Cacna1c 50 CTC CCA CTG TTT
GAG CCT GT and Cacna1c 30 TGT CTG CAG GTG GCA TAG. The
PCR amplification program consisted of: 94C for 4 min, followed by
35 cycles of 94C for 30 s, 60C for 45 s, and 72C for 60 s, and a
final 10 min at 72C. The DNA was separated by gel electrophoresis
(1% wt/vol agarose in TAE containing SYBR-safe from ThermoFisher)
and imaged using an Image Station 4000M PRO gel system running
Carestream software.
2.3 | Tamoxifen administration
Tamoxifen (Tx; Sigma) was reconstituted to 40 mg/mL in corn oil and
placed in a sonicating water bath for ≥1 hr until dissolved. From P60,
mice received 300 mg Tx per kilogram body weight daily for four con-
secutive days by oral gavage, as previously described (O'Rourke et al.,
2016; Young et al., 2013). Mice were analyzed at various timepoints
and referred to, for example, as P60 + 7, which indicates that the mice
were analyzed at P67, 7 days after the first dose of Tx at P60.
2.4 | Tissue preparation and immunolabeling
Mice were terminally anaesthetized with an intraperitoneal (i.p.) injec-
tion of sodium pentobarbital (30 mg/kg; Ilium) and then perfusion-
fixed with 4% (wt/vol) paraformaldehyde (PFA; Sigma) in phosphate
buffered saline (PBS). The brain and spinal cord were removed, and
the brain placed in a 1 mm brain matrix (Kent Scientific) and sliced
coronally to generate 2 mm tissue blocks. All tissue was postfixed in
4% PFA at room temperature for 90 min before being cryoprotected
in 20% (wt/vol) sucrose (Sigma) in PBS at 4C overnight. Tissue was
subsequently placed in cryomolds containing Shandon Cryomatrix
(ThermoFisher), frozen using liquid nitrogen and stored at −80C.
For immunolabeling, 30 μm coronal cryosections of the brain
(Bregma 0.62–1.18 mm) or transverse cryosections of the spinal cord
were collected and processed as floating sections. The primary anti-
bodies used were: goat anti-PDGFRα (1:200; GeneTex); rabbit anti-
NG2 (1:200, Millipore); mouse anti-CC1 (1:100 Calbiochem); rat anti-
GFP (1:2000; Nacalai Tesque), rabbit anti-cleaved caspase-3 (1:200,
Abcam); and rabbit anti-Iba1 (1:1,000; Synaptic Systems). Secondary
antibodies including donkey anti-goat (1:1,000), donkey anti-rabbit
(1:1,000), donkey anti-mouse (1:1,000), and donkey anti-rat (1:500)
were conjugated to Alexa Fluor −488, −568, or −647 (Invitrogen).
Nuclei were labeled using Hoechst 33342 (1:1,000; Invitrogen).
Mouse anti-CC1 was diluted in blocking solution containing 0.1%
(vol/vol) Triton X-100 and 10% fetal calf serum (FCS) in Tris buffered
saline. All other antibodies were diluted in PBS blocking solution
(0.1% [vol/vol] Triton X-100 and 10% FCS in PBS). Cryosections were
incubated with antibodies overnight at 4C on an orbital shaker. After
immunostaining, floating sections were mounted onto glass slides and
the fluorescence was preserved by the application of fluorescent
mounting medium (Dako) with the coverslip.
2.5 | 7, 5-Ethynyl-20-deoxyuridine development and
detection
From P60 + 7, 5-ethynyl-20-deoxyuridine (EdU; Invitrogen) was
administered to mice via their drinking water (0.2 mg/mL, as per
Young et al. (2013)) for 3, 6, 12, or 24 days. EdU labeling was visual-
ized using the Alexa Fluor-647 Click-iT EdU kit (Invitrogen). Floating
sections were incubated for 15 min in 0.5% Triton X-100 (vol/vol) in
PBS at room temperature. Cryosections were then transferred into
the EdU developing cocktail, incubated in the dark for 45 min then
washed in PBS before undergoing immunolabeling as described
above. Alternatively, EdU was reconstituted to 5 mg/mL in PBS and
filter sterilized, before being administered to P60 + 10 control and
CaV1.-2 deleted mice as 2x i.p. injections (each 25 mg/kg), 2 hr apart.
Mice were killed by cervical dislocation 2 hr after the final injection
(4 hr labeling period) and 200 μm thick coronal brain slices (generated
as detailed below for calcium imaging) were immersion fixed in 4%
PFA (wt/vol) in PBS for 90 min, prior to EdU developing.
2.6 | Microscopy
Low magnification (20×) confocal image z-stacks (3 μm spacing) were
acquired spanning each transverse spinal cord cryosection using a
spinning disk confocal microscope (DSD2, Andor). Images were
stitched (NIS-Elements, Nikon) to produce a single image for analysis.
All other confocal images were collected using an UltraView confocal
microscope with Volocity Software (Perkin Elmer) with standard exci-
tation and emission filters for DAPI (Hoechst 33342), FITC (Alexa
Fluor-488), TRITC (Alexa Fluor-568), and CY5 (Alexa Fluor-647).
A minimum of five cryosections were imaged per mouse. A series of
images were collected (20× air objective) to span the corpus callosum
or motor cortex (3 μm z-spacing), and images covering each region
were stitched together using the Volocity software. Images for
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internode analyses were collected using a 40× air objective and
0.5 μm z-steps. Cell number, protein colabeling, tissue area measure-
ments, and internode number and length measurements were made
manually from images using the ImageJ software (NIH; (Schindelin
et al., 2012)) or Adobe Photoshop, by researchers blinded to the
experimental condition.
2.7 | Electrophysiology
Following cervical dislocation, developing (P10-P15) or adult (P60-P84)
Pdgfrα-hGFP mice were decapitated and their brains dissected into an
ice-cold sucrose solution containing: 75 mM sucrose, 87 mM NaCl,
2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM NaHCO3, 7 mM MgCl2, and
0.95 mM CaCl2. Coronal vibratome slices (300 μm) were prepared using
a Leica VT1200s vibratome and incubated at 31.7C in artificial cere-
bral spinal fluid (ACSF) containing: 119 mM NaCl, 1.6 mM KCl, 1 mM
NaH2PO4, 26.2 mM NaHCO3, 1.4 mM MgCl2, 2.4 mM CaCl2, and
11 mM glucose (300 ± 5 mOsm/kg), saturated with 95% O2/5% CO2.
After 45 min, slices were transferred to ~21C ASCF.
Recordings of L-type VGCCs were undertaken based on protocols
in Fulton et al. (2010). Slices were transferred to a bath constantly per-
fused with ~21C ACSF (2 mL/min). Recording electrodes were pre-
pared from glass capillaries and had a resistance of 3–6 MΩ when filled
with an internal solution containing 125 mM Cs-methanesulfonate,
4 mM NaCl, 3 mM KCl, 1 mM MgCl2, 8 mM HEPES, 9 mM EGTA,
10 mM phosphocreatine, 5 mM MgATP, and 1 mM Na2GTP, set to a
pH of 7.2 with CsOH and an osmolarity of 290 ± 5 mOsm/kg. Whole
cell patch clamp recordings of GFP+ cells in the corpus callosum or
motor cortex were collected using a HEKA Patch Clamp EPC800 ampli-
fier and pCLAMP 10.5 software (Molecular devices). Due to the high
membrane resistance of OPCs (>1 GΩ), recordings were made without
series resistance compensation. Cells were held at −50 mV and a series
of voltage steps up to +30 mV applied to determine the presence of a
voltage-gated sodium channel current, the identity of which was con-
firmed by the bath application of tetrodotoxin (TTX, 500 nM; Abcam)
to a subset of cells (current at baseline: −232 ± 33 pA; current in the
presence of TTX: −21 ± 6 pA; n = 4, p = .0008, paired t test).
The perfusate was subsequently switched to a calcium recording
solution containing 20 mM BaCl2, 125 mM choline Cl, 5 mM
tetraethyl ammonium, 10 mM glucose, and 10 mM HEPES, set to a
pH of 7.4 with CsOH and an osmolarity of 300 ± 5 mOsm/kg. To
record L-type currents, cells were held at −50 mV and a series of
500 ms voltage steps, from −60 to +30 mV, was applied using a P/N
subtraction protocol. Recordings were taken once a minute for
≥5 min. During the first 2 min, the voltage-gated sodium current was
completely blocked and the VGCC current could be recorded, indicat-
ing sufficient solution exchange. To block L-type VGCC currents,
nifedipine (30 μM; Sigma) or nimodipine (10 μM; Sigma) was added to
the calcium recording solution. To block VGCC currents, cadmium
(100 μM; Sigma) was added to the calcium recording solution. Access
resistance was measured before and after each recording and an
access resistance >20 MΩ resulted in exclusion of that recording.
Measurements were made from each data file using Clampfit 10.5
(Molecular Devices). The steady-state current was measured during
the last 100 ms of each voltage step. The data file that produced the
largest inwards current in each cell was selected for analysis, and sta-
tistical tests were performed on the evoked current that had the larg-
est negative value (peak inward current), regardless of voltage step. In
experiments where multiple genotypes were analyzed, all recordings
were collected and analyzed by researchers unaware of the mouse
genotype.
2.8 | Calcium imaging
10 days after Tx administration (Tx + 10), Pdgfrα-hGFP (control) and
Pdgfrα-hGFP:: Cacna1cfl/fl (CaV1.2-deleted) mice were killed by cervi-
cal dislocation and each brain dissected into an ice-cold sucrose solu-
tion containing: 75 mM sucrose, 87 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 25 mM NaHCO3, 7 mM MgCl2, and 0.95 mM CaCl2. Coro-
nal vibratome slices (200 μm) were prepared using a Leica VT1200s
vibratome and incubated at ~32C in ACSF containing: 119 mM NaCl,
1.6 mM KCl, 1 mM NaH2PO4, 26.2 mM NaHCO3, 1.4 mM MgCl2,
2.4 mM CaCl2, and 11 mM glucose (300 ± 5 mOsm/kg), saturated
with 95% O2/5% CO2. After 45 min, brain slices were transferred
onto slice culture inserts (Millipore) suspended over 1 mL of ~21C
ASCF (saturated with 95% O2/5% CO2). A total of 5 μL of
DMSO/10% pluronic acid (ThermoFisher)/5 mg/mL Fura-2AM
(ThermoFisher) was added to the tissue surface and the brain slice
was incubated at 37C/5% CO2 for 20 min. Each slice was washed
with ACSF before being transferred to the microscope slice chamber,
and continually perfused with ACSF. After 3 min of baseline imaging,
slices were exposed to a depolarizing (high K+) ACSF for 2 min, which
contained: 74 mM NaCl, 50 mM KCl, 1 mM NaH2PO4, 26.2 mM
NaHCO3, 1.4 mM MgCl2, 2.4 mM CaCl2, and 11 mM glucose (300
± 5 mOsm/kg), saturated with 95% O2/5% CO2. Images were cap-
tured every 5 s for 10 min on an inverted microscope (TiE, Nikon),
equipped with a 40× Flour-S oil-immersion objective with DIC optics
(Nikon) and NIS Elements 6D software (Nikon). Fura-2AM was excited
at 340 and 380 nm with an attenuated illumination source (50% trans-
mission; Lambda DG-4; Sutter Instruments, Novato, CA). Images were
acquired at 510 nm with an EMCCD digital camera (Evolve 512; Pho-
tometrics) using regions of interest defined by NIS Elements software
(Nikon). After subtracting background fluorescence, a ratio (F) of fluo-
rescence at 340 nm to fluorescence at 380 nm was calculated in the
soma. Cells were subsequently classified as GFP+ or GFP-negative.
The Fura-2AM ratio was normalized to the baseline average (first
2 min) from each trace (F0). The maximum ΔF/F0 and area under the
curve (ΔF/F0. min−1) calculations were made using Prism (GraphPad
Software).
2.9 | Statistical analyses
Statistical comparisons were made using GraphPad Prism. Each data
set was first analyzed for normality using the KS normality test. As
our data passed the normality test, they were further analyzed using a
t test or one- or two-way analysis of variance (ANOVA) followed by a
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Bonferroni's multiple comparisons post hoc test as indicated. For elec-
trophysiological recordings, data are presented as mean ± SEM and
n represents the number of cells from a minimum of three mice. Inter-
node analyses are presented as mean ± SEM and n indicate the number
of oligodendrocytes. All other histological data are presented as mean
± SD and n represents the number of mice. The data that support the
findings of this study are available from the corresponding author upon
reasonable request.
3 | RESULTS
3.1 | CaV1.2 is the major L-type VGCC expressed by
adult OPCs
In order to determine whether CaV1.2 signaling regulates adult OPC
function, we first confirmed that adult OPCs had functional L-type
VGCCs. We performed a whole cell patch clamp analysis of GFP-
labeled OPCs in the motor cortex of acute brain slices generated from
P60 Pdgfrα-hGFP mice (Figure 1). The majority of GFP+ cells were
small cells with a membrane capacitance (Cm) <50 pF and a voltage-
gated sodium channel current >100 pA, which was sensitive to TTX
(Figure 1a,b), confirming that they were OPCs. OPCs were held at
−50 mV in a solution designed to isolate VGCC currents, and a series
of voltage steps applied from −60 to 30 mV. OPCs responded with an
inward current that appeared at approximately −30 mV, peaked at
0 mV, and was sensitive to the L-type VGCC antagonists nifedipine
(30 μM) or nimodipine (10 μM), or the nonspecific VGCC antagonist cad-
mium (100 μM) (Figure 1c–e). A minority of GFP+ cells had a Cm > 40 pF
(mean 67 ± 12 pF) and an inward voltage-gated sodium channel current
<100 pA (Figure 1a,b) and were classified as newly differentiated oligo-
dendrocytes (as per Clarke et al., 2012; Sahel et al., 2015). The magni-
tude of the inward VGCC current was smaller in newly differentiated
oligodendrocytes than in OPCs (Figure 1f–g). These data indicate that,
like developmental OPCs (Fulton et al., 2010; Hrvatin et al., 2018; Zhang
et al., 2014), adult OPCs express L-type VGCCs, that are downregulated
as they differentiate into oligodendrocytes.
To determine if L-type VGCC expression by OPCs differs with age
or brain location, we measured the VGCC current in OPCs located in
the motor cortex or corpus callosum of P10 or P60 mice. OPCs in the
corpus callosum consistently had a smaller Cm than OPCs in
the motor cortex (Figure 1h), suggesting that they are smaller. When
the peak inward current was normalized to Cm for each cell (peak
inward current/Cm = current density), we found that the magnitude of
the OPC peak inward voltage-gated sodium channel and L-type VGCC
currents were unaffected by brain region (Figure 1i,j). Furthermore,
while voltage-gated sodium channel current density was reduced in
adult OPCs compared with developmental OPCs (Figure 1i), VGCC cur-
rent density was equivalent for OPCs found in the P10 and P60 mouse
brain (Figure 1j). These data suggest that brain OPCs maintain VGCC
expression throughout development and into adulthood.
During development, CaV1.2 is the major channel contributing to
depolarization-induced calcium entry into OPCs (Cheli et al., 2016).
To determine whether CaV1.2 is also the major L-type channel in
adult OPCs, we conditionally deleted CaV1.2 from OPCs in the adult
mouse CNS. Tx was administered to P60 Pdgfrα-hGFP:: Cacna1cfl/fl
(Control) and Pdgfrα-CreER:: Pdgfrα-hGFP:: Cacna1cfl/fl (CaV1.2-deleted)
mice and L-type VGCC currents recorded from GFP+ OPCs in the
motor cortex of acute slices generated at P60 + 14. Tx administration
to control mice did not alter OPC VGCC current density (no Tx control
−2.1 ± 0.2 pA/pF vs. Tx control −2 ± 0.2 pA/pF; p = .7, unpaired t test).
However, Tx administration to CaV1.2-deleted mice reduced OPC
VGCC current density to −0.8 ± 0.1 pA/pF, which equated to a ~60%
reduction in the peak inward VGCC current density (Figure 2a–c). Fur-
thermore, the conditional deletion of CaV1.2 from adult OPCs signifi-
cantly reduced K+ depolarization-induced calcium entry into GFP+
OPCs in acute brain slices, without impacting calcium entry into GFP-
negative cells (Figure S2). These data indicate that CaV1.2 is the major
L-type VGCC in adult OPCs.
When comparing the peak L-type VGCC current density for con-
trol and CaV1.2-deleted OPCs, we noted that the majority of control
OPCs had a peak L-type VGCC current density between −2.6 and
−1.4 pA/pF (within 1 SD of the mean), while only 1 of the 13 OPCs
examined in the CaV1.2-deleted mice had a peak L-type VGCC cur-
rent density within this range (Figure 2a–c). Therefore, we conserva-
tively estimate that the Cacna1c gene was recombined and deleted
from ~92% of OPCs in these mice (12/13 × 100). This recombination
efficiency is in line with that previously reported for adult Pdgfrα-
CreER:: Rosa26-YFP mice that received an equivalent Tx treatment
(O'Rourke et al., 2016). When CaV1.2 was instead deleted from OPCs
using the less efficient Pdgfrα-CreERT2 transgenic mouse, the VGCC
current density was reduced by ~29% (control OPCs −2.1 ± 0.1 pA/pF,
n = 27; CaV1.2-deleted OPCs −1.5 ± 0.2 pA/pF, n = 12; unpaired
t test p = .001), suggesting that in these mice, the Cacna1c transgene
was successfully deleted from ~45% of OPCs (29% current reduc-
tion/60% current reduction × 0.92). Again, this recombination effi-
ciency is consistent with that previously reported for Pdgfrα-CreERT2::
Rosa26-YFP mice that received an equivalent Tx treatment (Rivers
et al., 2008).
3.2 | CaV1.2 does not affect adult OPC
differentiation or newborn oligodendrocyte
myelination
To determine whether CaV1.2 regulates OPC differentiation in the
adult CNS, we performed lineage tracing of adult OPCs. Tx was
administered to P60 Pdgfrα-CreERT2:: Tau-mGFP (Control) and Pdgfrα-
CreERT2:: Tau-mGFP:: Cacna1cfl/fl (CaV1.2-deleted) mice, to label adult
OPCs with a membrane-targeted form of GFP (mGFP) that is retained
by the pre-myelinating and myelinating oligodendrocytes they produce
in the motor cortex (Figure 3a–j) and corpus callosum (Figure 3k–t). As
the Tau-mGFP transgene recombines inefficiently to label only a subset
of OPCs in the adult mouse CNS, we performed immunohistochemistry
to detect PDGFRα and mGFP in the P60 + 30 brain, and found that an
equivalent fraction of PDGFRα+ OPCs were mGFP-labeled in the motor
cortex (Figure 3a,b,g) or corpus callosum (Figure 3k,l,q) of control and
CaV1.2-deleted mice.
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To determine whether CaV1.2-deletion altered the ability of adult
OPCs to produce myelinating oligodendrocytes, we morphologically
characterized the PDGFRα-negative mGFP+ cells, classifying them
as premyelinating (Figure 3c,d,m,n) or myelinating (Figure 3e,f,o,p)
oligodendrocytes (as per Young et al. (2013)). In the motor cortex of
P60 + 30 control and CaV1.2-deleted mice, PDGFRα+ mGFP+ OPCs
had differentiated to produce a small number of PDGFRα-negative
mGFP+ myelinating oligodendrocytes, that comprise ~20% of all
F IGURE 1 Legend on next page.
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mGFP+ cells in the region (Figure 3h). By contrast, PDGFRα+ mGFP+
OPCs in the corpus callosum of control and CaV1.2-deleted mice had
differentiated to produce many new mGFP+ myelinating oligodendro-
cytes that comprise ~60% of all callosal mGFP+ cells (Figure 3r). These
data indicate that adult OPCs in the corpus callosum of control and
CaV1.2-deleted mice produce myelinating oligodendrocytes more rapidly
than their cortical counterparts (p < .0001, unpaired t test). However, the
number of mGFP+ myelinating oligodendrocytes was equivalent between
control and CaV1.2-deleted mice in each region (Figure 3h,r), indicating
that CaV1.2 does not influence the number of OPCs that differentiate
into myelinating oligodendrocytes in the adult mouse brain.
To determine whether CaV1.2 could influence the maturation of
adult-born oligodendrocytes, as reported in development (Cheli et al.,
2016), we next examined the morphology of individual myelinating oli-
godendrocytes in the motor cortex (Figure 3e,f,i,j) and corpus callosum
(Figure 3o,p,s,t) of P60 + 30 control and CaV1.2-deleted mice. In the
motor cortex, individual newborn, myelinating oligodendrocytes elabo-
rated a smaller number of mGFP+ internodes than those added to the
corpus callosum (compare control Figure 3i,s; p < .0001, unpaired t test).
However, the deletion of CaV1.2 from adult OPCs did not affect the
ability of newborn oligodendrocytes to produce the normal number of
myelin internodes (Figure 3i,s), nor did it affect the length of the inter-
nodes produced (Figure 3j,t). These data suggest that adult-born oligo-
dendrocytes do not require CaV1.2 for myelination.
As Pdgfrα-CreERT2:: Cacna1cfl/fl mice only delete CaV1.2 from
approximately half of adult OPCs (see above), we confirmed this
phenotype using Pdgfrα-CreER:: Cacna1cfl/fl transgenic mice. We
administered EdU to P60 + 7 control and Pdgfrα-CreER:: Cacna1cfl/fl
(CaV1.2-deleted) mice for 24 consecutive days, and performed immu-
nohistochemistry to detect EdU and the oligodendrocyte marker CC1
in the motor cortex (Figure 4a,b) and corpus callosum (Figure 4c,d).
Consistent with our lineage tracing data (Figure 3), an equivalent den-
sity of EdU-labeled CC1+ newborn oligodendrocytes accumulated in
the motor cortex and corpus callosum of control and CaV1.2-deleted
(Pdgfrα-CreER:: Cacna1cfl/fl) mice during the labeling period (Figure 4e),
confirming that CaV1.2 expression by OPCs does not impact
oligodendrogenesis in adult mice.
F IGURE 1 Adult oligodendrocyte progenitor cells (OPCs) express L-type voltage-gated calcium channel (VGCCs). Whole cell patch clamp
recordings were made from GFP+ cells in acute brain slices from Pdgfrα-hGFP transgenic mice. (a) Representative traces of voltage-gated sodium
channel currents evoked in a GFP+ OPC (in the absence and presence of tetrodotoxin [TTX]) or a newborn oligodendrocyte (oligo) by a
depolarizing step from −50 to 0 mV. (b) Peak inward voltage-gated sodium currents were measured in GFP+ cells in the absence or presence of
TTX, and the magnitude of the evoked current was used to distinguish OPCs (n = 8) from oligos (n = 5). (c) Graphical representation of the
current–voltage relationship for leak subtracted L-type VGCC currents recorded from GFP+ OPCs in the P60 mouse motor cortex (MC) under
control (CTRL) conditions (closed squares, n = 8) or in the presence of the L-type VGCC antagonist nifedipine (30 μM; open circles, n = 7).
(d) Representative traces depicting the current evoked by a depolarizing step from −50 to 0 mV in the absence (black) or presence (gray) of
nifedipine. (e) The peak inward calcium current recorded from OPCs during a series of depolarizing steps under control conditions or in the
presence of nifedipine, nimodipine, or cadmium. (f) Representative traces depicting the L-type VGCC current evoked by a depolarizing step from
−50 to 0 mV in a GFP+ OPC or oligo. (g) Peak inward L-type VGCC calcium current measured in GFP+ OPCs or Oligos during a series of
depolarizing steps. (h) The membrane capacitance (pF) of OPCs in the mouse corpus callosum (CC; P10, n = 14; P60, n = 8) or MC (MC; P10,
n = 12; P60, n = 9). (i) Voltage-gated sodium channel current density for OPCs from the MC or CC at P10 or P60. (j) L-type VGCC current
density for OPCs in the P10 and P60 MC or CC. Data are represented at mean ± SEM. ***p < .001. Data were analyzed using an unpaired t test
(2 bar graphs), one-way or two-way analysis of variance (ANOVA) with Bonferroni's posttest
F IGURE 2 CaV1.2 is themajor voltage-gated calcium channel
(VGCC) expressed by adult oligodendrocyte progenitor cells (OPCs).
(a) Graphical representation of the current density-voltage relationship for
leak-subtracted L-typeVGCC currents recorded fromOPCs in themotor
cortex of P60 + 14 control (filled squares, n = 10) or CaV1.2-deleted
(Pdgfrα-CreER : :Cacna1cfl/fl; open squares, n = 13)mice. (b) The peak
inward current density of L-typeVGCC currents recorded from control
(filled squares) or CaV1.2-deleted (open squares) OPCs during a series of
depolarizing voltage steps (p < .001, unpaired t test). (c) Representative
traces showing the leak-subtracted calcium current evoked in response to
a depolarizing step from−50 to 0mV. Values representmean ± SEM
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3.3 | CaV1.2 suppresses adult OPC proliferation
To examine the influence that CaV1.2 signaling exerts on adult OPC
proliferation, we provided EdU to P60 + 7 control and Pdgfrα-CreER::
Cacna1cfl/fl (CaV1.2-deleted) mice, via the drinking water for up to
24 days, and performed immunohistochemistry to detect EdU and
PDGFRα in the motor cortex (Figure 4f–m) and corpus callosum
(Figure 4n–u). After 6 and 12 days of EdU delivery (P60 + 13 or
P60 + 19), we detected a small but significant increase in the propor-
tion of EdU-labeled PDGFRα+ OPC (EdU+ PDGFRα+/total PDGFRα+;
Figure 4v) in themotor cortex of CaV1.2-deletedmice, relative to control
mice (Figure 4v). More specifically, we found that the conditional dele-
tion of CaV1.2 from adult OPCs significantly increasedOPC proliferation
in the superficial layers of the motor cortex (Figure S3). Furthermore, by
F IGURE 3 Legend on next page.
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providing EdU for a longer time period (24 days), we determined that
CaV1.2 signaling in OPCs influenced their rate of proliferation, but did
not influence the total proportion of OPCs capable of dividing (the prolif-
erative fraction), as essentially all OPCs had become EdU-labeled by
P60 + 31 in control and CaV1.2-deletedmice (Figure 4v).
CaV1.2 similarly suppresses OPC proliferation in the corpus cal-
losum of adult mice, as the fraction of callosal OPCs that incorporated
EdU over a 3 (P60 + 10) or 6 (P60 + 13) day labeling period was ele-
vated in CaV1.2-deleted mice, compared to control mice (Figure 4w).
Consistent with this finding, the acute delivery of EdU to P60 + 10
mice (by i.p. injection), to label OPCs that proliferate within a 4-hr
window, revealed that approximately twice as many OPCs incorpo-
rated EdU in CaV1.2-deleted mice than control mice (Figure S4). How-
ever, CaV1.2 did not influence the proportion of OPCs capable of
dividing in the corpus callosum, as essentially all OPCs were EdU-
labeled following 12 or 24 days of EdU delivery to mice of either
genotype (P60 + 19 and P60 + 31; Figure 4w). Therefore, we con-
clude that CaV1.2 reduces the rate of OPC proliferation in the healthy
adult mouse motor cortex and corpus callosum but does not impact
the fraction of OPCs that are capable of division.
3.4 | CaV1.2 is essential for the survival of OPCs in
the adult mouse corpus callosum, but not the motor
cortex or spinal cord
To investigate the possibility that CaV1.2 could regulate OPC number
in the brain, we quantified the density of PDGFRα+ OPCs in the motor
cortex (Figure 5a–g) and corpus callosum (Figure 5h–p) of control and
CaV1.2-deleted (Pdgfrα-CreER:: Cacna1cfl/fl) mice. We found that the
density of PDGFRα+ OPCs did not vary significantly between P60 + 4
and P60 + 30 in the motor cortex of control or CaV1.2-deleted mice
and was equivalent to the OPC density of mice that did not receive
tamoxifen (plotted as P60 + 0; Figure 5g). OPC density was also stable
over time in the corpus callosum of control mice but OPC density
dropped significantly between P60 + 4 and P60 + 7 in the corpus cal-
losum of CaV1.2-deleted mice, such that at P60 + 7, the density of
PDGFRα+ OPCs was only ~42% that of control mice (Figure 5p). OPC
density remained low in the corpus callosum of P60 + 10 CaV1.2-deleted
mice but returned to control levels by P60 + 13 (Figure 5p). NG2+ cell
density was similarly reduced in the corpus callosum of P60 + 10
CaV1.2-deleted mice, when compared to control mice (Figure S4e–g),
confirming that CaV1.2 deletion resulted in OPC loss rather than the loss
of PDGFRα expression by OPCs. As this reduction in OPC density was
not recapitulated by the partial pharmacological blockade of CaV1.2,
achieved by giving daily injections of nimodipine (as per Schampel et al.
(2017)) for up to seven consecutive days (Figure S5), it is likely that OPC
density can only be compromised by the complete and sustained loss of
CaV1.2 signaling, as was achieved by our gene deletion approach.
To determine whether CaV1.2 affects OPC number in other white
matter regions of the CNS, we performed immunohistochemistry to
detect PDGFRα+ OPCs in the spinal cord gray (Figure 6a–g) and white
matter (Figure 6h–n) of control and CaV1.2-deleted (Pdgfrα-CreER::
Cacna1cfl/fl) mice. OPC density was higher in the spinal gray matter
relative to the spinal cord white matter in mice of both genotypes
(compare Figure 6g with Figure 6n; p < .001 regional affect, two-way
ANOVA), and OPC density was not affected by CaV1.2 expression in
either spinal cord region between P60 + 0 and P60 + 10 (Figure 6g,n),
the period corresponding with OPC loss from the corpus callosum.
These data suggest that CaV1.2 supports the survival of a subset of
OPCs in the corpus callosum, but that CaV1.2 is not critical for the
survival of OPCs in all white matter regions of the CNS.
3.5 | Callosal OPCs die by apoptosis and are replaced
by parenchymal OPCs that lack CaV1.2
To determine whether callosal OPC density decreases in
CaV1.2-deleted mice because OPCs undergo apoptotic cell death, we
stained coronal brain cryosections from P60 + 4 control and Pdgfrα-
CreER:: Cacna1cfl/fl (CaV1.2-deleted) mice to determine whether
PDGFRα+ OPCs expressed the apoptotic marker, cleaved caspase
3 (Figure 7a–f). While OPC density was equivalent in the corpus cal-
losum of P60 + 4 control and CaV1.2-deleted mice (Figure 5p), the den-
sity of PDGFRα+ Caspase3+ OPCs had already risen in the corpus
callosum of CaV1.2-deleted mice to be >threefold higher than the
basal level of apoptosis observed in controls (Figure 7g). The fraction
of OPCs that expressed caspase 3 increased from ~4% in control
mice to ~15% in CaV1.2-deleted mice (Figure 7h). These data sug-
gest that the death of CaV1.2-deleted callosal OPCs occurs rapidly
F IGURE 3 CaV1.2 is not required for oligodendrogenesis in the adult mouse brain. Brain cryosections from P60 + 30 control (CTRL) or
CaV1.2-deleted (Pdgfrα-CreERT2:: Cacna1cfl/fl) mice were immunolabeled to detect membrane targeted (m) GFP (green) and PDGFRα (red).
Representative images of mGFP+ PDGFRα+ oligodendrocyte progenitor cells (OPCs) (a,b), PDGFRα-negative premyelinating oligodendrocytes
(c,d), and PDGFRα-negative myelinating oligodendrocytes (e,f) from the motor cortex (MC) of control and CaV1.2-deleted mice. (g) The fraction
of OPCs that recombine to express mGFP in the MC of control (n = 5) and CaV1.2-deleted (n = 7) mice. (h) The proportion of mGFP+ cells in the
MC that are OPCs, premyelinating oligodendrocytes or myelinating oligodendrocytes. (i) Average internode number per mGFP+ myelinating
oligodendrocyte in the MC of control (n = 40 cells) and CaV1.2-deleted (n = 71 cells) mice. (j) Average internode length per mGFP+ myelinating
oligodendrocyte in the MC of control and CaV1.2-deleted mice. Representative images of mGFP+ OPCs (k,l), premyelinating oligodendrocytes
(m,n), and myelinating oligodendrocytes (o,p) in the corpus callosum (CC) of control or CaV1.2-deleted mice. (q) The fraction of OPCs that
recombine to express mGFP in the CC of control (n = 5) and CaV1.2-deleted (n = 7) mice. (r) The proportion of mGFP+ cells in the CC that are
OPCs, premyelinating oligodendrocytes or myelinating oligodendrocytes. (s) Average internode number per mGFP+ myelinating oligodendrocyte
in the CC of control (n = 36 cells) and CaV1.2-deleted (n = 49 cells) mice. (t) Average internode length per mGFP+ myelinating oligodendrocyte in
the CC of control and CaV1.2-deleted mice. Data are represented at mean ± SD, except for internode analyses, which are represented as mean
± SEM. Scale bars represent 10 μm [Color figure can be viewed at wileyonlinelibrary.com]
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F IGURE 4 CaV1.2-deletion increases adult oligodendrocyte progenitor cell (OPC) proliferation. Control (CTRL) and CaV1.2-deleted (Pdgfrα-
CreER:: Cacna1cfl/fl) mice received 7, 5-ethynyl-20-deoxyuridine (EdU) from P60 + 7 for up to 24 days before 30 μm brain cryosections were
immunostained to detect EdU (green) and the oligodendrocyte marker CC1 (red) or the OPC marker PDGFRα (red). Representative images of
newborn EdU-labeled CC1+ oligodendrocytes in the motor cortex (MC) of control (a) and CaV1.2-deleted (b) mice and the corpus callosum
(CC) of control (c) and CaV1.2-deleted (d) mice. (e) Quantification of the density (per mm2) of EdU+ CC1+ newborn oligodendrocytes in the MC
and CC of control and CaV1.2-deleted mice, after 24 consecutive days of EdU administration. Representative images of EdU-labeled PDGFRα+
OPCs in the MC of control (f–i) and CaV1.2-deleted (j–m) mice, and in the CC of control (n–q), and CaV1.2-deleted (r–u) mice. (v) Quantification
of the proportion of OPCs in the MC that incorporate EdU over time. (w) Quantification of the proportion of OPCs in the CC that incorporate
EdU over time. Note that the EdU labeling of OPCs is saturated within 12 days of EdU delivery. Data are represented as the mean ± SD of
n = 4–7 mice per genotype per timepoint. *p < .05 and **p < .01, two-way analysis of variance (ANOVA) with Bonferroni's posttest. Scale bars
represent 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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following CaV1.2 loss. When making whole cell patch clamp record-
ings from healthy OPCs in the corpus callosum, we found no statisti-
cally significant difference between the peak inward L-type VGCC
current density of control and CaV1.2-deleted OPCs at P60 + 4
(Figure 7i,j), suggesting that many OPCs still have intact CaV1.2 at this
early timepoint. However, approximately half of the CaV1.2-deleted
OPCs had a peak inward L-type VGCC current density below that
observed in any control OPC (Figure 7i–k), suggesting that a subset of
OPCs have lost or are losing CaV1.2 at the time of increased apoptosis.
For OPC density to return to normal in the corpus callosum of
CaV1.2-deleted mice by P60 + 13, new OPCs must be generated from
the surviving parenchymal OPCs and/or from nearby neural stem
cells. As neural stem cells do not express Pdgfrα, CaV1.2 would not be
deleted from these cells at the time of Tx administration, and com-
plete replacement of the lost callosal OPCs by neural stem cells would
result in approximately half of callosal OPCs having intact CaV1.2
expression in P60 + 20 mice. Conversely, if the lost callosal OPCs
were replaced by surviving CaV1.2-deleted parenchymal OPCs, all
F IGURE 5 CaV1.2-deletion leads to oligodendrocyte progenitor cells (OPCs) loss in the corpus callosum (CV) of adult mice. 30 μm brain
cryosections were collected from control and CaV1.2-deleted (Pdgfrα-CreER:: Cacna1cfl/fl) mice spanning P60 + 0 to P60 + 30 and stained to detect
PDGFRα (red). Images show OPCs in the motor cortex (MC) of control (a–c) or CaV1.2-deleted mice (d–f). (g) Quantification of the number of
PDGFRα+ OPCs per mm2 (x-y) in the MC of control (closed squares) and CaV1.2-deleted (open squares) mice. (h) Low magnification image of the
CC of a P60 + 10 control mouse stained to detect PDGFRα+ OPCs. (i) Low magnification image of the CC of a P60 + 10 CaV1.2-deleted mouse
stained to detect PDGFRα+ OPCs. Images show OPCs in the CC of control (j–l) or CaV1.2-deleted (m–o) mice. (p) Quantification of the number of
PDGFRα+ OPCs per mm2 (x-y) in the CC of control (closed squares) and CaV1.2-deleted (open squares) mice (genotype effect at P60 + 7 and P60
+ 10; p < .001, two-way analysis of variance (ANOVA) with Bonferroni's posttest). Data are represented as the mean ± SD of n = 4–7 mice per
genotype per timepoint. Scale bars represent 20 μm (a–f, j–o) or 50 μm (h–i) [Color figure can be viewed at wileyonlinelibrary.com]
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OPCs in the repopulated corpus callosum would lack CaV1.2 at P60
+ 20. To examine the origin of the replacement cells, we performed a
whole cell patch clamp analysis of OPCs at P60 + 20, and found that
OPCs in the corpus callosum of CaV1.2-deleted mice had a peak
inward L-type VGCC current ~52% smaller than that of control OPCs
at the same timepoint (Figure 7i–k). Furthermore, the L-type VGCC
current density measured for each OPC patched in the corpus cal-
losum of P60 + 20 CaV1.2-deleted mice was smaller than any of the
L-type VGCC current densities measured from OPCs in control mice
(within the range of −3.2 pA/pF to −1.9 pA/pF), suggesting that all
OPCs sampled lacked CaV1.2. While these data do not exclude the
possibility that neural stem cells from the subventricular zone contrib-
ute in some small way to the repopulation, the absence of a large sub-
set of callosal OPCs with intact L-type VGCC currents suggests that
OPCs in the corpus callosum of P60 + 20 CaV1.2-deleted mice are
primarily the surviving CaV1.2-deficient parenchymal OPCs and their
progeny.
4 | DISCUSSION
4.1 | CaV1.2 is not required for oligodendrogenesis
or myelination in the healthy adult CNS
OPCs express various receptors and ion channels that enable them to
respond to changes in neuronal activity by increasing intracellular cal-
cium (reviewed by Pitman and Young (2016)), however, there is lim-
ited research exploring how this could change as mice age. Our data
indicate that adult OPCs express L-type VGCCs, particularly CaV1.2
(Figures 1, 2, and S2) and, consistent with previous findings in devel-
opmental OPCs (Fulton et al., 2010; Hrvatin et al., 2018; Zhang et al.,
2014), these channels are downregulated as they differentiate into oli-
godendrocytes (Figure 1). We report that the conditional deletion of
Cacna1c (CaV1.2) from adult OPCs (Figure 2) increases OPC prolifera-
tion (Figure 4; Figures S3 and S4) but does not affect the number of
newborn oligodendrocytes added to the mature brain (Figures 3 and 4),
or the ability of newborn oligodendrocytes to myelinate (Figure 3).
F IGURE 6 CaV1.2 does not influence oligodendrocyte progenitor cell (OPC) density in the spinal cord. 30 μm spinal cord
(SC) cryosections from control and CaV1.2-deleted (Pdgfrα-CreER:: Cacna1cfl/fl) mice aged P60 + 0 to P60 + 10 were immunostained to
detect PDGFRα (red). Representative images of PDGFRα+ OPCs in the spinal cord gray matter of control (a–c) and CaV1.2-deleted (d–f )
mice. (g) Quantification of the number of PDGFRα+ OPCs per mm2 (x-y) in the spinal cord gray matter of control (closed squares)
and CaV1.2-deleted (open squares) mice. Representative images of PDGFRα+ OPCs in the spinal cord white matter of control (h–j)
and CaV1.2-deleted (k–m) mice. (n) Quantification of the number of PDGFRα+ OPCs per mm2 (x-y) in the spinal cord white matter of
control (closed squares) and CaV1.2-deleted (open squares) mice. Data are represented as the mean ± SD of n = 3–6 mice per genotype
and timepoint. Scale bars represent 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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These data are not consistent with the phenotype produced by the
knockdown or conditional deletion of Cacna1c from developmental
OPCs, where it has been shown to inhibit OPC proliferation and dif-
ferentiation (Cheli et al., 2015, 2016) and result in hypomyelination
of the brain (Cheli et al., 2016). It is perhaps surprising that the dele-
tion of CaV1.2 from developmental OPCs impairs oligodendrocyte
maturation, when CaV1.2 is downregulated with differentiation, but
may suggest that calcium entry through CaV1.2 into developmental
but not adult OPCs can have a long-lasting effect on intracellular
signaling or lead to their secretion of prodifferentiation signals.
Alternatively, CaV1.2 could become restricted to the processes of
new oligodendrocytes in development, but not in adulthood, such
that the associated voltage-gated calcium signal cannot be readily
detected at the soma but could still influence developmental mye-
lination. For example, action potentials are known to produce local
calcium signals in internodes to influence the rate of internode
extension and retraction in the developing CNS (Baraban, Koudelka, &
Lyons, 2018; Krasnow, Ford, Valdivia, Wilson, & Attwell, 2018); how-
ever, it is not clear whether this type of myelin regulation requires
CaV1.2.
F IGURE 7 A subset of CaV1.2-deleted callosal oligodendrocyte progenitor cells (OPCs) undergo caspase 3-mediated apoptosis. (a–c)
Representative image of the corpus callosum (CC) of a P60 + 4 control mouse stained to detect PDGFRα+ OPCs (red) and the apoptotic marker
cleaved caspase 3 (casp3; green). (d–f) Representative image of the CC of a P60 + 4 CaV1.2-deleted (Pdgfrα-CreER:: Cacna1cfl/fl) mouse stained to
detect PDGFRα+ OPCs (red) and the apoptotic marker cleaved caspase 3 (casp3; green). Arrow heads indicate colabeled cells. (g) Quantification of
the density of Caspase3+ PDGFRα+ OPCs per mm2 (x-y; 30 μm cryosections) of the CC in control (n = 3) and CaV1.2-deleted (n = 3) mice.
(h) Quantification of the proportion of OPCs that express caspase 3 in control or CaV1.2 deleted mice. (i) Graphical representation of the current
density-voltage relationship for L-type voltage-gated calcium channel (VGCC) currents recorded from GFP+ OPCs in the CC of acute brain slices
from control (filled squares; n = 6) mice at P60 + 20, or CaV1.2-deleted mice at P60 + 4 (open squares; n = 7) and P60 + 20 (gray squares; n = 8).
(j) The peak inward L-type VGCC current density recorded from OPCs in slices generated from control (filled squares) mice at P60 + 20, or
CaV1.2-deleted mice at P60 + 4 (open squares) or P60 + 20 (gray squares). (k) Example traces show the leak-subtracted voltage-gated calcium
current in response to a depolarizing step from −50 to 0 mV in OPCs from P60 + 20 control or CaV1.2-deleted mice. Histological data are
represented as mean ± SD and electrophysiological data are represented as mean ± SEM. *p < .05, **p < .01, t test, one-way, or two-way analysis
of variance (ANOVA) with Bonferroni's posttest. Scale bars represent 20 μm [Color figure can be viewed at wileyonlinelibrary.com]
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As the L-type VGCC currents measured in OPCs were unchanged
between development and adulthood (Figure 1), a change in the
expression of CaV1.2 is unlikely to account for the switch in CaV1.2
function over this period. However, VGCCs are activated by changes
in membrane voltage, and their function can be influenced by the
altered expression or activation of a number of other ion channels,
including voltage-gated sodium and potassium channels (Sun, Mat-
thews, Nicolas, Schoch, & Dietrich, 2016), as the expression of these
channels decreases from development to adulthood (Clarke et al.,
2012; Spitzer et al., 2019; present data), or ionotropic glutamate or
GABA receptors (Haberlandt et al., 2011; reviewed by Pitman and
Young (2016)). The altered expression of these signaling proteins in
OPCs could cause CaV1.2 to be activated less frequently in the adult
mouse brain and limit the ability of CaV1.2 to be a dominant signal
regulating OPC differentiation. It is also possible that CaV1.2 activity
is affected by changes in the way that OPCs communicate with neu-
rons and other CNS cell types in the developing versus adult CNS.
OPCs can communicate with neurons via GABAergic and gluta-
matergic synapses (Bergles, Roberts, Somogyi, & Jahr, 2000; Lin &
Bergles, 2004) that are lost with increasing postnatal age in some brain
regions, including the rat caudal cerebellar peduncle (Gautier et al.,
2015) and mouse somatosensory cortex (Velez-Fort, Maldonado, Butt,
Audinat, & Angulo, 2010). Neuronal activity-induced changes in OPC
behavior could also result from changes in other modes of communica-
tion, such as the non-synaptic release of molecules from axons
(Maldonado, Velez-Fort, Levavasseur, & Angulo, 2013), the secondary
release of signaling molecules from astrocytes (Hamilton, Vayro,
Wigley, & Butt, 2010), or extrasynaptic signaling resulting from neuro-
transmitter spill-over from neuron–neuron synapses (Velez-Fort et al.,
2010). While it is unclear how callosal OPC inputs and signaling can
change with aging, it is interesting to note that demyelination restores
neuron-OPC synaptic communication in the rat caudal cerebellar
peduncle (Gautier et al., 2015) and causes adult OPCs in the corpus cal-
losum to revert to a transcriptional state similar to that of develop-
mental OPCs (Moyon et al., 2015). Such changes could account for
CaV1.2 having no effect on adult myelination in the healthy adult
mouse brain but acting to expedite or enhance remyelination of
the corpus callosum following cuprizone-induced demyelination
(Santiago González et al., 2017).
4.2 | CaV1.2 is a survival signal for a subpopulation
of callosal OPCs
A key finding of this study is that CaV1.2 is critical for the survival of
approximately half of all OPCs in the adult mouse corpus callosum. At
P60 + 4, when the density of OPCs in the corpus callosum of
CaV1.2-deleted mice was normal (Figure 5), a subset of CaV1.2-deleted
OPCs had already entered the apoptotic cell death pathway (Figure 7),
and by P60 + 7, the density of OPCs in the corpus callosum of
CaV1.2-deleted mice was reduced by ~58% (Figure 5). By contrast,
OPC density in the motor cortex remained normal. These data indicate
that CaV1.2 differentially regulates the survival of adult OPCs, which is
consistent with previous reports that OPCs respond heterogeneously
to some survival and cell death signals. To give examples, G protein-
coupled receptor 17 (GPR17)-positive OPCs are more sensitive to ATP-
induced cell death than GPR17-negative OPCs in vitro (Ceruti et al.,
2011), and developmental but not adult OPCs rely on poly (RDP-ribose)
polymerase (PARP) activity for their survival (Baldassarro, Marchesini,
Giardino, & Calzà, 2017). Additionally, the chromatin remodeler, Ch7,
selectively promotes the survival of noncycling OPCs in the developing
mouse corpus callosum and cortex, by downregulating p53 (Marie
et al., 2018).
CaV1.2 could enhance OPC survival by modulating known OPC
survival signals, such as the expression or activity of the growth factor
receptors activated by PDGF-AA (Barres et al., 1992a, 1992b), neuro-
trophin 3 (Kumar, Kahn, Dinh, & de Vellis, 1998) and ciliary neurotropic
factor (Dell'Albani et al., 1998; Talbott et al., 2007). By increasing p65
NFκB expression, factors secreted by microglia can increase the effi-
cacy of PDGF-AA signaling on cultured OPCs (Nicholas, Wing, &
Compston, 2001), and tenascin-C also promotes the survival of OPCs
growing on poly-lysine, by allowing them to respond to PDGF-AA
(Garwood et al., 2004). In vivo, OPCs rely on the HMG domain tran-
scription factors, Sox9 and Sox10, to maintain PDGFRα expression and
prevent their apoptotic cell death (Finzsch, Stolt, Lommes, & Wegner,
2008). However, CaV1.2 also promotes the survival of neurons in the
developing mouse (P0–P18) cortex (Heck et al., 2008), superior olivary
complex (Ebbers et al., 2015) and hippocampus (Lee et al., 2016), and
calcium entry through CaV1.2 may instead promote OPC survival by
increasing the activity of the cyclic-AMP response element binding pro-
tein (CREB), a transcription factor expressed by OPCs (Zhang et al.,
2014), and a downstream mediator of the CaV1.2-dependent survival
of cortical neurons (Heck et al., 2008). Further research is required to
uncover the mechanism by which CaV1.2 activity enhances the survival
of a discrete population of adult OPCs in vivo.
4.2.1 | Do functional subpopulations of OPCs exist
in the brain?
It is intriguing that adult OPCs in the motor cortex and corpus cal-
losum express CaV1.2 at similar levels, and yet only a subset of OPCs
in the corpus callosum are reliant on CaV1.2 for their survival. Previ-
ous studies have shown that OPCs in different CNS regions prolifer-
ate at different rates, with OPCs in the white matter proliferating
more rapidly than OPCs in gray matter (Young et al., 2013; present
data), and that OPCs can differentially respond to growth factors, with
cortical and cerebellar white but not gray matter OPCs proliferating in
response to PDGF-AA, despite their equivalent expression of PDGFRα
(Hill, Patel, Medved, Reiss, & Nishiyama, 2013). OPCs in the corpus cal-
losum and motor cortex have been previously subdivided based on
their mixed origins in the lateral ganglionic eminence or cortical neuro-
epithelium (Kessaris et al., 2006), and brain OPCs can also be sub-
divided based on their expression of GRP17 (Boda et al., 2011), S100β
(Hachem et al., 2005; Vives, Alonso, Solal, Joubert, & Legraverend,
2003), or the transcription factor Ascl1 (Mash1; Battiste et al., 2007;
Parras et al., 2007; Nakatani et al., 2013). However, a clear overlap
between any of these known subsets and the OPCs that require
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CaV1.2 for survival seems unlikely, as OPCs in the cortex have a simi-
larly mixed origin (Kessaris et al., 2006) and contain OPCs that express
GPR17 (Boda et al., 2011), Ascl1 (Nakatani et al., 2013) and S100β
(Young et al., 2010) that do not die following CaV1.2 deletion.
Perhaps callosal OPCs are selectively dependent on CaV1.2 for
their survival because of the level of CaV1.2 signaling they experience
within their local environment. We have shown that all OPCs in the
healthy mouse brain express L-type VGCCs (see control recordings in
Figures 2 and 7), and that CaV1.2, as the major L-type VGCC, enables
calcium entry into OPCs following K+-induced depolarization
(Figure S2). Furthermore, we show that CaV1.2 signaling impacts
OPCs proliferation (Figure 4) in the healthy adult mouse brain,
suggesting that CaV1.2 is activated under physiological conditions.
However, these experiments do not tell us how often OPCs within
different regions of the CNS depolarize and activate L-type VGCCs.
High voltage activated VGCCs open when a cell is depolarized to >
−40 mV, making it possible that a subset of callosal OPCs become
reliant on CaV1.2 for their survival because they are more frequently
depolarized and their L-type VGCCs more frequently activated. In the
CA1 stratum radiatum, stimulation mimicking physiological gluta-
matergic synaptic signaling was able to induce both dendritic and
somatic VGCC-dependent calcium transients in OPCs in brain slices
from P7-15 mice, providing evidence that synaptic signaling can depo-
larize OPCs and activate VGCCs (Sun et al., 2016). However, these
calcium transients were largely mediated via low-voltage activated
channels (Sun et al., 2016), suggesting that, at least in the CA1 stratum
radiatum of developing mice, high voltage activated L-type VGCCs
may not be activated in this way. At present, we do not know which
physiological conditions or patterns of signaling allows OPCs to
become sufficiently depolarized to activate L-type VGCCs, although
OPCs express a complement of ion channels that can enable mem-
brane depolarization, such as voltage-gated sodium channels (Clarke
et al., 2012), ionotropic glutamate or GABA receptors (Haberlandt
et al., 2011), or purinergic ion channels (Hamilton et al., 2010) that are
likely sources of physiological L-type VGCC activation.
Adult OPCs that do not rely on CaV1.2 for survival may instead
rely on an alternative source of calcium. In addition to voltage-gated
calcium entry, OPCs can rely on store-operated calcium channels
(Paez et al., 2009); however, an increase in store-operated calcium
entry between development and adulthood would be predicted to
increase the stromal interaction molecule 1-mediated suppression of
calcium entry via CaV1.2 and reduce the cell surface expression of
CaV1.2 (Park, Shcheglovitov, & Dolmetsch, 2010; Wang et al., 2010),
both of which would have reduced the OPC L-type VGCC current.
OPCs that do not rely on CaV1.2 for their survival may still rely on cal-
cium entry through calcium-permeable ionotropic receptors, including
AMPA receptors (Haberlandt et al., 2011), NMDA receptors (Hamilton
et al., 2010), and P2X purinergic receptors (Hamilton et al., 2010). Alter-
natively, neurotransmitters including glutamate (Haberlandt et al.,
2011), ATP (Hamilton et al., 2010), and acetylcholine (Welliver et al.,
2018) can increase intracellular calcium via activation of Gαq-coupled
G-protein coupled receptors. Interestingly, expression of the Group
1 metabotropic glutamate receptors, mGluR1 and mGluR5, is not
uniform across OPCs in the developing mouse hippocampus
(Haberlandt et al., 2011) and NMDA receptor-dependent calcium tran-
sients are only detected in ~20% of OPCs in the mouse optic nerve
(Hamilton et al., 2010), suggesting that some alternative avenues for
activity-dependent calcium entry into OPCs may be restricted to
subpopulations of OPCs.
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